We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
Cap. Flow
+$4.56B
Cap. Flow %
5.05%
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344

Sector Composition

Rank Sector Weight
1 Financials 11.61%
2 Technology 10.97%
3 Healthcare 10.51%
4 Consumer Discretionary 7.19%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UAN icon
3876
CVR Partners
UAN
$1.29B
$98K ﹤0.01%
+1,194
New +$98.5K
AMBR
3877
DELISTED
Amber Road Inc
AMBR
$97K ﹤0.01%
+12,547
New +$73.2K
AXGN icon
3878
Axogen
AXGN
$2.19B
$96K ﹤0.01%
13,944
-25,493
-65% -$144K
MX icon
3879
Magnachip Semiconductor
MX
$118M
$95K ﹤0.01%
+16,795
New +$89.6K
NEOS
3880
DELISTED
Neos Therapeutics, Inc
NEOS
$95K ﹤0.01%
+10,271
New +$98K
EMKR
3881
DELISTED
Emcore Corp
EMKR
$95K ﹤0.01%
1,594
-2,428
-60% -$137K
SRNE
3882
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$94K ﹤0.01%
16,665
+3,271
+24% +$20.9K
ELOS
3883
DELISTED
Syneron Medical Ltd
ELOS
$94K ﹤0.01%
12,176
+1,673
+16% +$11.9K
TPLM
3884
DELISTED
Triangle Petroleum Corporation
TPLM
$92K ﹤0.01%
+319,930
New +$121K
RGNX icon
3885
Regenxbio
RGNX
$615M
$91K ﹤0.01%
+11,390
New +$126K
MTBL
3886
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$91K ﹤0.01%
+34,214
New +$133K
MCBC
3887
DELISTED
Macatawa Bank Corp
MCBC
$90K ﹤0.01%
12,129
-82,661
-87% -$574K
GALT icon
3888
Galectin Therapeutics
GALT
$223M
$89K ﹤0.01%
60,617
-979
-2% -$1.44K
TLYS icon
3889
Tilly's
TLYS
$118M
$89K ﹤0.01%
15,402
+5,326
+53% +$32.6K
RST
3890
DELISTED
ROSETTA STONE INC
RST
$89K ﹤0.01%
11,407
-28,120
-71% -$214K
GRBK icon
3891
Green Brick Partners
GRBK
$3.18B
$88K ﹤0.01%
+12,231
New +$89.2K
TTOO
3892
DELISTED
T2 Biosystems, Inc
TTOO
$88K ﹤0.01%
+2
New +$90.3K
PMTS icon
3893
CPI Card Group
PMTS
$243M
$87K ﹤0.01%
3,486
+1,334
+62% +$41.1K
TTNP
3894
DELISTED
Titan Pharmaceuticals
TTNP
$87K ﹤0.01%
+4
New +$85.2K
OCUL icon
3895
Ocular Therapeutix
OCUL
$1.85B
$86K ﹤0.01%
+17,451
New +$173K
CCEC
3896
Capital Clean Energy Carriers
CCEC
$1.36B
$84K ﹤0.01%
4,020
+591
+17% +$12.4K
AVID
3897
DELISTED
Avid Technology Inc
AVID
$84K ﹤0.01%
+14,540
New +$85.6K
CETV
3898
DELISTED
Central European Media Enterprises Ltd
CETV
$84K ﹤0.01%
39,457
+17,148
+77% +$42.6K
ECYT
3899
DELISTED
Endocyte, Inc. Common Stock
ECYT
$84K ﹤0.01%
26,308
+1,826
+7% +$6.69K
IMN
3900
DELISTED
Imation
IMN
$84K ﹤0.01%
+66,894
New +$106K

Similar funds

Credit Suisse's Q2 2016 Portfolio in Review

As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.

  • Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
  • Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
  • Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
  • Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
  • Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
  • Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.

Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.